Abstract
The Generating Evidence in Oncology (GEO) research environment integrates multiple real-world administrative claims and clinical datasets to provide a unique platform for oncology research. This study described GEO patient demographics and contrasted them to the American Community Survey (ACS) and the US Cancer Statistics Public Use Database (USCS), which includes cancer incidence data from 50 states and territories. The study focused on non-small cell lung cancer (NSCLC).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have